OKT4/OKT8 ratio and serum beta 2-microglobulin in mycosis fungoides and chronic benign dermatitis
- 1 June 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (6) , 663-669
- https://doi.org/10.1016/0277-5379(86)90163-x
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Characterization of T-Cell Subpopulations in Skin and Peripheral Blood of Patients with Cutaneous T-Cell Lymphomas and Benign Inflammatory DermatosesJournal of Investigative Dermatology, 1983
- Differential loss of T lymphocyte markers in advanced cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1982
- Early diagnosis of mycosis fungoides and Sézary's syndrome by morphometric analysis of lymphoid cells in the skinCancer, 1980
- Monoclonal Antibodies Defining Distinctive Human T Cell Surface AntigensScience, 1979
- The patch stage of mycosis fungoides Criteria for histologic diagnosisThe American Journal of Dermatopathology, 1979
- β2-MICROGLOBULIN, A TUMOUR MARKER OF LYMPHOPROLIFERATIVE DISORDERSThe Lancet, 1978
- β2-Microglobulin levels in cancerous and other disease statesClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Complete amino acid sequence of β2-microglobulinBiochemistry, 1973
- Serum β2-microglobulin in various disordersClinica Chimica Acta; International Journal of Clinical Chemistry, 1973
- The Serum Levels and Urinary Excretion of β2-Microglobulin in Apparently Healthy SubjectsScandinavian Journal of Clinical and Laboratory Investigation, 1972